Florian Douam, PhD
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Virology, Immunology & Microbiology

PhD, L'École Normale Supérieure de Lyon
BS, Universite De Tours



Florian Douam, Ph.D. is an Assistant Professor of Microbiology at Boston University Chobanian and Avedisian School of Medicine and a core investigator at the National Emerging Infectious Diseases Laboratories (NEIDL). Dr. Douam has a PhD in molecular virology and more than a decade of experience investigating virus biology in cell culture and animal models. Specifically, Dr. Douam is a viral immunologist with deep expertise in generating and using innovative mouse models to investigate viral pathogenesis and immune responses to viruses in BSL-2 and BSL-3 laboratories. At the NEIDL, he leads a research team focused on identifying the molecular and cellular mechanisms shaping immune outcomes in human RNA virus infections, employing a variety of viral pathogens from mosquito-borne viruses to coronaviruses.

Faculty
Boston University
National Emerging Infectious Disease Lab


Graduate Medical Sciences Educator and Mentor (Primary Mentor of Graduate Students)
Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences




A self-amplifying RNA-based synthetic nanobody platform for next-generation therapeutics
08/01/2025 - 04/30/2029 (Multi-PI)
PI: Florian Douam, PhD
NIH/National Institute of Biomedical Imaging & Bioengineering
1R01EB038005-01

Human cutaneous responses to arthropod-mediated viral transmission
07/08/2025 - 07/07/2027 (PI)
NIH/National Institute of Allergy & Infectious Diseases
1R21AI193648-01

Characterizing A Novel Humanized Mouse Platform To Model Arbovirus Transmission
11/01/2024 - 10/31/2026 (Subcontract PI)
Health Resources in Action, Inc. Richard/Susan Smith


Reverse genetic tools and novel models of henipavirus infection
10/28/2022 - 09/30/2026 (Co-Investigator)
PI: Elke Muhlberger, PhD
Bill and Melinda Gates Foundation


Low-dose RNA vaccine platform for tickborne flaviviruses
03/01/2024 - 09/30/2024 (Subcontract PI)
Tiba Biotech LLC NIH NIAID
1R43AI165194-01A1

Evaluation of mRNA-based vaccine approaches against endemic coronaviruses
12/07/2021 - 09/30/2024 (PI)
Moderna Therapeutics


CFAR Developmental Award: A humanized mouse model to investigate the impact of HIV persistence and antiretroviral treatment on vaccine-induced immune responses
07/01/2023 - 06/30/2024 (Subcontract PI)
The Miriam Hospital NIH NIAID
2P30AI042853-25

Evaluation of mRNA-based vaccine approaches against DENV
03/14/2023 - 05/30/2024 (Multi-PI)
PI: Florian Douam, PhD
Moderna Therapeutics


Characterization of a human-specific positive regulator of flavivirus infection
04/12/2021 - 03/31/2024 (PI)
NIH/National Institute of Allergy & Infectious Diseases
3K22AI144050-02S1

Defining the Impact of Per/Polyfluoroalkyl Substance Exposure on Susceptibility to SARS-CoV-2 Infection and Disease
03/02/2021 - 02/29/2024 (Multi-PI)
PI: Florian Douam, PhD
NIH/National Institute of Environmental Health Sciences
5R21ES032882-02

Showing 10 of 11 results. Show All Results


Title

Immunogenicity and efficacy studies of mRNA-LNP against COVID-19 in hamsters
07/01/2025 - 06/30/2027 (Multi-PI)
PI: Florian Douam, PhD
MGH/Moderna SRA

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Website       Copy PMIDs To Clipboard

  1. Unali G, Douam F. Orthoflavivirus Vaccine Platforms: Current Strategies and Challenges. Vaccines (Basel). 2025 Sep 29; 13(10). PMID: 41150403; PMCID: PMC12568211; DOI: 10.3390/vaccines13101015;
     
  2. Kenney D, O'Connell AK, Tseng AE, Turcinovic J, Sheehan ML, Nitido AD, Montanaro P, Gertje HP, Ericsson M, Connor JH, Vrbanac V, Crossland NA, Harly C, Balazs AB, Douam F. Immune signatures of SARS-CoV-2 infection resolution in human lung tissues. PLoS Pathog. 2025 Sep; 21(9):e1013469.View Related Profiles. PMID: 40920821; PMCID: PMC12425302; DOI: 10.1371/journal.ppat.1013469;
     
  3. Kenney D, Matsuo M, Unali G, Wacquiez A, Saeed M, Douam F. Comprehensive Analysis of the Impact of Weight Loss Thresholds on Mouse Models of Fatal Viral Infection. Viruses. 2025 Sep 07; 17(9).View Related Profiles. PMID: 41012653; PMCID: PMC12474137; DOI: 10.3390/v17091225;
     
  4. Zhang J, Chavez EC, Winkler M, Liu J, Carver S, Lin AE, Biswas A, Tamura T, Tseng A, Wang D, Benhamou A, O' Connell AK, Matsuo M, Norton JE, Kenney D, Adamson B, Kleiner RE, Burwitz B, Crossland NA, Douam F, Ploss A. Amino acid changes in two viral proteins drive attenuation of the yellow fever 17D vaccine. Nat Microbiol. 2025 Aug; 10(8):1902-1917.View Related Profiles. PMID: 40629111; PMCID: PMC12313524; DOI: 10.1038/s41564-025-02047-y;
     
  5. Caobi A, Su CM, Beusch CM, Kenney D, Darling TL, Feng S, Semaan M, Wacquiez A, Sanders NL, Tully ES, Chen DY, Evdokimova M, Ding Z, Jones D, Alysandratos KD, Mizgerd JP, Kirchdoerfer RN, Kotton DN, Douam F, Crossland NA, Boon ACM, Gordon DE, Baker SC, Saeed M. SARS-CoV-2 nsp15 enhances viral virulence by subverting host antiviral defenses. Proc Natl Acad Sci U S A. 2025 Jun 17; 122(24):e2426528122.View Related Profiles. PMID: 40504150; PMCID: PMC12184426; DOI: 10.1073/pnas.2426528122;
     
  6. Shastry A, Hiller BE, Sanders NL, Tseng AE, Kothari J, O'Connell AK, Gertje HP, Ha CT, Murzin E, Traber KE, Lederer JA, Jones MR, Douam F, Beach TG, Remick DG, Crossland NA, Monti S, Campbell JD, Mizgerd JP. Sub-phenotypes of pneumonia defined by pulmonary histopathological features. bioRxiv. 2025 May 20.View Related Profiles. PMID: 40475544; PMCID: PMC12139937; DOI: 10.1101/2025.05.18.654716;
     
  7. Mcconney CS, Kenney D, Ennis CS, Smith-Mahoney EL, Ayuso MJ, Zhong J, Douam F, Sagar M, Snyder-Cappione JE. Individuals Infected with SARS-CoV-2 Prior to COVID-19 Vaccination Maintain Vaccine-Induced RBD-Specific Antibody Levels and Viral Neutralization Activity for One Year. Viruses. 2025 Apr 29; 17(5).View Related Profiles. PMID: 40431652; PMCID: PMC12115583; DOI: 10.3390/v17050640;
     
  8. Subramaniam S, Jose A, Kenney D, O'Connell AK, Bosmann M, Douam F, Crossland N. Challenging the notion of endothelial infection by SARS-CoV-2: insights from the current scientific evidence. Front Immunol. 2025; 16:1443932.View Related Profiles. PMID: 39967675; PMCID: PMC11832389; DOI: 10.3389/fimmu.2025.1443932;
     
  9. Subramaniam S, Napoleon MA, Lotfollahzadeh S, Kamal MH, Kurniawan H, Elsadawi M, Kenney D, Douam F, Bosmann M, Whelan S, Cabral H, Burks EJ, Zhao G, Kolachalama V, Ravid K, Chitalia V. Tryptophan metabolism reprogramming contributes to the prothrombotic milieu in mice and humans infected with SARS-CoV-2. bioRxiv. 2025 Jan 30.View Related Profiles. PMID: 39896681; PMCID: PMC11785031; DOI: 10.1101/2025.01.17.633602;
     
  10. Joseph J, Baby HM, Quintero JR, Kenney D, Mebratu YA, Bhatia E, Shah P, Swain K, Lee D, Kaur S, Li XL, Mwangi J, Snapper O, Nair R, Agus E, Ranganathan S, Kage J, Gao J, Luo JN, Yu A, Park D, Douam F, Tesfaigzi Y, Karp JM, Joshi N. Toward a Radically Simple Multi-Modal Nasal Spray for Preventing Respiratory Infections. Adv Mater. 2024 Nov; 36(46):e2406348.View Related Profiles. PMID: 39318086
     
Showing 10 of 54 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 54 publications over 13 distinct years, with a maximum of 9 publications in 2025

YearPublications
20121
20132
20144
20155
20161
20172
20185
20204
20216
20224
20236
20245
20259
Contact for Mentoring:
Douam's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department